CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' (DEFICIT) EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Common Stock	Accumulated Deficit
Balance, beginning of period at Jan. 29, 2022	$ 81,126	$ 175,856	$ (94,730)
Balance, beginning of period (in shares) at Jan. 29, 2022		12,631,347
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options	16	$ 16
Exercise of stock options (in shares)		2,705
Restricted stock issued (in shares)		797,849
Net share settlement of stock options and restricted stock units	(2,375)	$ (2,375)
Net share settlement of stock options and restricted stock units (in shares)		(224,320)
Stock-based compensation expense	548	$ 548
Repurchase and retirement of common stock	(6,253)		(6,253)
Repurchase and retirement of common stock (in shares)		(479,966)
Net Income (Loss)	(7,855)		(7,855)
Balance, end of period at Apr. 30, 2022	65,207	$ 174,045	(108,838)
Balance, end of period (in shares) at Apr. 30, 2022		12,727,615
Balance, beginning of period at Jan. 29, 2022	81,126	$ 175,856	(94,730)
Balance, beginning of period (in shares) at Jan. 29, 2022		12,631,347
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options	$ 16
Repurchase and retirement of common stock (in shares)	(479,966)
Net Income (Loss)	$ (40,901)
Balance, end of period at Oct. 29, 2022	$ 33,065	$ 174,949	(141,884)
Balance, end of period (in shares) at Oct. 29, 2022	12,754,368	12,754,368
Balance, beginning of period at Apr. 30, 2022	$ 65,207	$ 174,045	(108,838)
Balance, beginning of period (in shares) at Apr. 30, 2022		12,727,615
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock issued (in shares)		28,574
Net share settlement of stock options and restricted stock units	(8)	$ (8)
Net share settlement of stock options and restricted stock units (in shares)		(1,821)
Stock-based compensation expense	617	$ 617
Net Income (Loss)	(25,705)		(25,705)
Balance, end of period at Jul. 30, 2022	40,111	$ 174,654	(134,543)
Balance, end of period (in shares) at Jul. 30, 2022		12,754,368
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 295	$ 295
Repurchase and retirement of common stock (in shares)	0
Net Income (Loss)	$ (7,341)		(7,341)
Balance, end of period at Oct. 29, 2022	$ 33,065	$ 174,949	(141,884)
Balance, end of period (in shares) at Oct. 29, 2022	12,754,368	12,754,368
Balance, beginning of period at Jan. 28, 2023	$ 29,773	$ 175,450	(145,677)
Balance, beginning of period (in shares) at Jan. 28, 2023	12,754,368	12,754,368
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock issued (in shares)		86,824
Net share settlement of stock options and restricted stock units	$ (76)	$ (76)
Net share settlement of stock options and restricted stock units (in shares)		(28,294)
Stock-based compensation expense	490	$ 490
Net Income (Loss)	(12,107)		(12,107)
Balance, end of period at Apr. 29, 2023	18,080	$ 175,864	(157,784)
Balance, end of period (in shares) at Apr. 29, 2023		12,812,898
Balance, beginning of period at Jan. 28, 2023	$ 29,773	$ 175,450	(145,677)
Balance, beginning of period (in shares) at Jan. 28, 2023	12,754,368	12,754,368
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options	$ 0
Repurchase and retirement of common stock (in shares)	0
Net Income (Loss)	$ (37,868)
Balance, end of period at Oct. 28, 2023	$ (7,285)	$ 176,260	(183,545)
Balance, end of period (in shares) at Oct. 28, 2023	12,923,677	12,923,677
Balance, beginning of period at Apr. 29, 2023	$ 18,080	$ 175,864	(157,784)
Balance, beginning of period (in shares) at Apr. 29, 2023		12,812,898
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock issued (in shares)		104,475
Stock-based compensation expense	124	$ 124
Net Income (Loss)	(19,364)		(19,364)
Balance, end of period at Jul. 29, 2023	(1,160)	$ 175,988	(177,148)
Balance, end of period (in shares) at Jul. 29, 2023		12,917,373
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock issued (in shares)		8,334
Net share settlement of stock options and restricted stock units	(5)	$ (5)
Net share settlement of stock options and restricted stock units (in shares)		(2,030)
Stock-based compensation expense	$ 277	$ 277
Repurchase and retirement of common stock (in shares)	0
Net Income (Loss)	$ (6,397)		(6,397)
Balance, end of period at Oct. 28, 2023	$ (7,285)	$ 176,260	$ (183,545)
Balance, end of period (in shares) at Oct. 28, 2023	12,923,677	12,923,677